Mendus
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
IMMU | ST
Overview
Corporate Details
- ISIN(s):
- SE0005003654 (+1 more)
- LEI:
- 529900AFBGFR7ZB50J95
- Country:
- Sweden
- Address:
- Västra Trädgårdsgatan 15, 111 53 Stockholm
- Website:
- https://mendus.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Mendus is a clinical-stage biotechnology company dedicated to developing immunotherapies for cancer treatment. The company focuses on preventing tumor recurrence by stimulating the patient's immune system to build active immunity against residual cancer cells. Specializing in allogeneic dendritic cell biology, Mendus aims to improve long-term survival outcomes and preserve the quality of life for cancer patients. Its lead product candidate, vididencel, is under development for various malignancies, including ovarian cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Date | Filing | Language | Size | Actions | |
---|---|---|---|---|---|
2025-10-02 08:00 |
Regulatory News Service
Mendus meddelar uppdaterad klinisk strategi och operativt fokus
|
Swedish | 138.6 KB | ||
2025-10-02 08:00 |
Regulatory News Service
Mendus announces updated clinical strategy and operational focus
|
English | 137.5 KB | ||
2025-08-21 08:00 |
Quarterly Report
|
Swedish | 1.4 MB | ||
2025-08-21 08:00 |
Quarterly Report
|
English | 1.4 MB | ||
2025-08-20 18:00 |
Transaction in Own Shares
Mendus AB (publ) has resolved to transfer own shares on Nasdaq Stockholm
|
English | 117.2 KB | ||
2025-08-20 18:00 |
Transaction in Own Shares
Mendus AB (publ) har beslutat om överlåtelse av egna aktier
|
Swedish | 117.4 KB | ||
2025-06-30 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i Mendus AB (publ)
|
Swedish | 124.2 KB | ||
2025-06-30 08:00 |
Share Issue/Capital Change
Change in number of shares and votes in Mendus AB (publ)
|
English | 123.6 KB | ||
2025-05-26 17:50 |
Remuneration Information
Mendus AB (publ) har beslutat om emission av C-aktier och överlåtelse av egna s…
|
Swedish | 117.6 KB | ||
2025-05-26 17:50 |
Share Issue/Capital Change
Mendus AB (publ) has decided on directed issues of Class C shares and transfer …
|
English | 118.1 KB | ||
2025-05-06 10:10 |
Post-Annual General Meeting Information
Kommuniké från årsstämma i Mendus AB (publ) den 6 maj 2025
|
Swedish | 128.6 KB | ||
2025-05-06 10:10 |
Post-Annual General Meeting Information
Report from the Annual General Meeting of Mendus AB (publ) on 6 May 2025
|
English | 128.9 KB | ||
2025-05-06 08:00 |
Earnings Release
|
Swedish | 1.4 MB | ||
2025-05-06 08:00 |
Quarterly Report
|
English | 1.4 MB | ||
2025-02-13 08:00 |
Earnings Release
|
Swedish | 1.5 MB |
Automate Your Workflow. Get a real-time feed of all Mendus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Mendus via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2025-03-11 | Erik Manting | Other | Buy | 7,780 | 56,249.40 SEK |
2025-03-11 | Erik Manting | Other | Buy | 7,780 | 55,704.80 SEK |
2025-02-25 | Sven Arne Andreasson | Other | Buy | 25,000 | 198,750.00 SEK |
2024-04-02 | Erik Manting | Other | Other | 885,648 | 425,111.04 SEK |
2024-04-02 | Dharminder Chahal | Other | Other | 882,048 | 423,383.04 SEK |
2024-04-02 | Leopold Bertea | Other | Other | 267,858 | 128,571.84 SEK |
2022-10-25 | Sven Arne Andreasson | Other | Sell | 15,000 | 31,950.00 SEK |
2022-10-12 | Sven Arne Andreasson | Other | Sell | 10,000 | 18,800.00 SEK |
2022-05-20 | Erik Manting | Other | Buy | 37,059 | 86,347.47 SEK |
2022-05-19 | Ann-Charlotte Ferm | Other | Buy | 100,000 | 215,900.00 SEK |